Scientists at St. Jude Children’s Research Hospital identified chemokines expressed by osteosarcoma that improved CAR T-cell homing, with...

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma...

A collaborative study published in Nature reveals the functional relevance of tumor-neuron interactions that regulate the growth of...

Using patients’ own genetics to tailor their chemotherapy regimens appears to improve outcomes in children with acute myeloid leukemia, a...

Children from poor families are less likely to survive cancer, particularly if they are not white, a new study reports. Read more:...

A new drug that potentially works against all main types of primary bone cancer in children has been described by the scientists who...

Researchers revealed an unexpected way in which the protein OTX2 drives the progression of medulloblastoma -- the most common aggressive...

In a report published in Nature Medicine, St. Jude scientists examined how ALL cells respond to different therapeutics in the context of...

Pediatric acute myeloid leukemia (AML) accounts for 20% of all pediatric leukemia cases and is associated with poor outcomes, especially...

In a recent phase 2 clinical trial for children with craniopharyngioma, researchers at St. Jude found that photon therapy and the more...